Screener
Amphastar Pharmaceuticals AMPH Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's operating lease liabilities (current)?
- Amphastar Pharmaceuticals (AMPH) reported operating lease liabilities (current) of $8.8M in Q2 2026.
- How has Amphastar Pharmaceuticals's operating lease liabilities (current) changed year-over-year?
- Amphastar Pharmaceuticals's operating lease liabilities (current) increased by 11.7% year-over-year, from $7.88M to $8.8M.
- What is the long-term trend for Amphastar Pharmaceuticals's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's operating lease liabilities (current) has grown at a 18.8% compound annual growth rate (CAGR), from $3.36M to $7.93M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Amphastar Pharmaceuticals's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude